Gout Equals Diabetes in Stroke Risk
Cardiovascular disease prevention and treatment strategies for patients with diabetes may apply.
Rheumatoid Arthritis Disease Activity Boosts Coronary Risks
Acute coronary syndrome incidence has declined but remains significantly higher in patients with rheumatoid arthritis.
Hydroxychloroquine for Lupus Thins Thrombosis Risk
Long-term use of HCQ and low dose aspirin may work to reduce cardiovascular events.
Lupus Increases Cardiovascular Risk
Greater vigilance in monitoring for these outcomes and their modifiable risk factors is recommended.
Heart Disease in Lupus More Common than Previously Thought
EULAR 2017: Although already known to be highly prevalent, this test reveals that cardiovascular events are even more widespread in lupus.
Which is safer? Celecoxib? Naproxen? Ibuprofen?
The long-awaited results from the PRECISION trial are in — with some caveats. In this slideshow, we summarize the results.
Preventing Cardiovascular Disease Progression in Psoriasis
Biologic anti-inflammatory agents can lead to a drop in coronary artery disease in psoriasis patients, a study shows.
A Novel Approach to Isolating a Rare, but Treatable Pathogen
Case Study Summary: Acute pericarditis in a patient treated with adalimumab for psoriatic arthritis. Common oral pathogen identified as the aetiological agent.
Depression and Progression of Heart Disease in Lupus
Study suggests that depression may lead to an increased risk of subclinical atherosclerosis in women with systemic lupus erythematosus.
CMR Reveals Undetected Cardiac Disease in Rheumatology
Cardiovascular MRI can uncover previously undetected cardiac disease in patients with connective tissue disorders. An international group of experts recommends specific uses.